Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 21 June 2017, the Cambodia Oxford Medical Research Unit (COMRU) and Angkor Hospital for Children (AHC) hosted the kick-off meeting for the multi-country Real-time Tracking of Neglected Bacterial Infectious Diseases Resistance Patterns Asia (TuNDRA) study.

Group photo in Siem Reap

Investigators discussed final details of this 5-year study, which will enrol children aged 0-59 months in Cambodia, Bangladesh and Viet Nam who have been hospitalised with suspected invasive bacterial infection. TuNDRA will identify the bacteria causing severe infections, the antibiotic resistance in those organisms and determine the proportion of children with suspected bacterial infection who are potentially unnecessarily treated with antibiotics.

“The study is important given current global concerns about antimicrobial resistance (AMR),” said study collaborator and COMRU Director Dr Paul Turner. “Very few sites in low- and middle-income Asian countries are doing systematic collection of blood cultures in children with suspected invasive bacterial infection.”

TuNDRA will recruit in Bangladesh (Dhaka, Child Health Research Foundation), Cambodia (Angkor Hospital for Children, COMRU), and Vietnam (Ho Chi Minh City, OUCRU). The study is funded by the German Federal Ministry of Health and co-ordinated by the Robert Koch Institute (RKI), Germany and the International Vaccine Institute (IVI), South Korea.

TuNDRA investigators will collect samples to determine the bacteria responsible for these infections and their antimicrobial resistance profiles. Bacterial isolates will be sent to Prof Stephen Baker at OUCRU for whole genome sequencing at regular intervals throughout the study. In addition to culture, blood will tested for detection of dengue infection and swabs will be collected for PCR detection of key respiratory viruses.

“Incorporating near real-time whole genome sequencing of key bacterial species will allow us to generate data on the prevalence and genetic mechanisms associated with anti-microbial resistance across the region,” noted Dr. Turner.

The kick-off meeting was followed by a one-day training on study procedures and data entry. Recruitment is expected to begin in early July.

Similar stories

Researchers call for antimicrobial resistance surveillance to be improved

The number of studies reporting antimicrobial resistance (AMR) data has increased in Africa, South and South East Asia according to new research in the International Journal of Infectious Diseases.

Bacterial infections linked to one in eight global deaths, according to GRAM study

Data showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings

Study shows clear link between antibiotic treatment and acquisition of AMR bacteria in children

A study of the genetic diversity of Streptococcus pneumoniae, the bacterium responsible for hundreds of thousands of infant deaths each year, found that deep sequencing whole pneumococcal populations gave unsurpassed sensitivity for detecting multiple colonisations and was twice as effective at detecting invasive virulent strains of the bacteria as current best methods, say researchers in a study published in Nature Microbiology.

PRIORITISE study team publishes results, now seeks partners

In regions where few people have received Covid-19 vaccines, health systems remain vulnerable to surges in SARS-CoV-2 infections. During the delta-wave of COVID-19 in India, for example, healthcare facilities and staff across the country struggled to cope with the surge in the number of cases of COVID-19 due to a shortage of hospital beds for people with severe cases, plus shortages of medicines and limited human resources.

AMR and scrub typhus among Chiangrai Unit's research priorities

Which infections are most common in the Chiangrai region? How should we treat them and how can we improve diagnostic? Which strategies are most effective in directing antibiotic treatment? Blog by Carlo Perrone, research physician based at the Chiang Rai Clinical Research Unit in Chiangrai, Thailand.

Researchers call for access to Ivermectin for young children

Millions of children weighing less than 15kg are currently denied access to Ivermectin treatment due to insufficient safety data being available to support a change to the current label indication. The WorldWide Antimalarial Resistance Network’s new meta-analysis provides evidence that supports removing this barrier and improving treatment equity.